PAVmed Inc. (PAVM) Free cash flow 2016–2025
PAVmed Inc. (PAVM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.2MFY2025 · since FY2016: -$4.5M → -$5.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.2M | +84.4% |
| FY2024 | -$33.6M | +35.7% |
| FY2023 | -$52.3M | +27.9% |
| FY2022 | -$72.5M | -72.4% |
| FY2021 | -$42.1M | -91.5% |
| FY2020 | -$22.0M | -64.1% |
| FY2019 | -$13.4M | -51.8% |
| FY2018 | -$8.8M | -33.3% |
| FY2017 | -$6.6M | -47.7% |
| FY2016 | -$4.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PAVM financial trends
PAVM RevenuePAVM Net incomePAVM Net marginPAVM Gross profitPAVM Gross marginPAVM Operating incomePAVM Operating marginPAVM Operating cash flowPAVM Capital expendituresPAVM Return on equityPAVM Stock buybacksPAVM Dividends paidPAVM Total assetsPAVM Total liabilitiesPAVM Shareholders’ equityPAVM overview →